| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
32,633,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,434,166 |
Avg
Vol: |
665,294 |
| 52
Week Range: |
$21.74 - $21.74 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Research Services |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Boyer Milton |
SVP, Drug Product Manufacturin |
• – – |
2017-02-04 |
4 |
D |
$18.52 |
$6,278 |
D/D |
(339) |
29,102 |
|
- |
|
| D Ambra Thomas E Phd |
Chairman, Board of Directors |
– • – |
2017-02-04 |
4 |
D |
$18.52 |
$19,150 |
D/D |
(1,034) |
2,474,287 |
|
- |
|
| Henderson Lori M |
SVP, Secretary & Gen Counsel |
• – – |
2017-01-31 |
4 |
D |
$18.11 |
$20,030 |
D/D |
(1,106) |
50,231 |
|
- |
|
| D Ambra Thomas E Phd |
Chairman, Board of Directors |
– • – |
2017-01-31 |
4 |
D |
$18.11 |
$51,161 |
D/D |
(2,825) |
2,475,321 |
|
- |
|
| Conway Christopher M. |
SVP, Discovery and Development |
• – – |
2017-01-31 |
4 |
D |
$18.11 |
$19,215 |
D/D |
(1,061) |
40,957 |
|
- |
|
| Hagen Steven R |
SVP Manufacturing & Pharmaceut |
• – – |
2017-01-31 |
4 |
D |
$18.11 |
$19,233 |
D/D |
(1,062) |
33,851 |
|
- |
|
| Svokos George |
Chief Operating Officer |
• – – |
2017-01-06 |
4 |
D |
$18.98 |
$67,094 |
D/D |
(3,535) |
105,645 |
|
- |
|
| Marth William S |
President and CEO |
• • – |
2017-01-01 |
4 |
D |
$18.63 |
$156,958 |
D/D |
(8,425) |
517,030 |
|
- |
|
| Conway Christopher M. |
SVP, Discovery and Development |
• – – |
2016-12-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
42,018 |
|
- |
|
| Boyer Milton |
SVP Drug Product Manufacturing |
• – – |
2016-12-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
29,441 |
|
- |
|
| Maddaluna Anthony J |
Director |
– • – |
2016-12-02 |
4 |
B |
$16.46 |
$24,986 |
D/D |
1,518 |
7,408 |
2.39 |
- |
|
| Hagen Steven R |
SVP Manufacturing & Pharmaceut |
• – – |
2016-11-30 |
4 |
S |
$16.71 |
$150,390 |
D/D |
(9,000) |
34,913 |
|
- |
|
| Hagen Steven R |
SVP Manufacturing & Pharmaceut |
• – – |
2016-11-30 |
4 |
OE |
$13.20 |
$118,800 |
D/D |
9,000 |
43,913 |
|
- |
|
| Henderson Lori M |
SVP, Secretary & Gen Counsel |
• – – |
2016-11-16 |
4 |
S |
$17.00 |
$102,000 |
D/D |
(6,000) |
51,337 |
|
- |
|
| D Ambra Thomas E Phd |
Chairman, Board of Directors |
– • – |
2016-11-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
2,478,146 |
|
- |
|
| D Ambra Thomas E Phd |
Chairman, Board of Directors |
– • – |
2016-11-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,700 |
2,488,146 |
|
- |
|
| Hagen Steven R |
SVP Manufacturing & Pharmaceut |
• – – |
2016-11-10 |
4 |
S |
$16.79 |
$13,180 |
D/D |
(785) |
34,913 |
|
- |
|
| Henderson Lori M |
SVP, Secretary & Gen Counsel |
• – – |
2016-11-02 |
4 |
D |
$15.09 |
$6,172 |
D/D |
(409) |
57,337 |
|
- |
|
| Svokos George |
Chief Operating Officer |
• – – |
2016-11-02 |
4 |
D |
$15.09 |
$12,329 |
D/D |
(817) |
109,180 |
|
- |
|
| Hagen Steven R |
SVP Manufacturing & Pharmaceut |
• – – |
2016-11-02 |
4 |
D |
$15.09 |
$7,017 |
D/D |
(465) |
35,698 |
|
- |
|
| Ryan Una S |
Director |
– • – |
2016-10-05 |
4 |
D |
$16.91 |
$59,151 |
D/D |
(3,498) |
43,043 |
|
- |
|
| Ryan Una S |
Director |
– • – |
2016-10-05 |
4 |
OE |
$11.83 |
$59,150 |
D/D |
5,000 |
46,541 |
|
- |
|
| Mandarin Capital Management Secondary Sa |
|
– – – |
2016-09-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,051,295 |
|
- |
|
| Hagen Steven R |
SVP Manufacturing & Pharmaceut |
• – – |
2016-08-09 |
4 |
S |
$15.29 |
$21,421 |
D/D |
(1,401) |
36,163 |
|
- |
|
| Clessidra S.g.r. S.p.a. |
|
– – – |
2016-07-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,051,295 |
|
- |
|
292 Records found
|
|
Page 3 of 12 |
|
|
